NSC |
Compound |
Enrichment |
Correlation |
NSC 85700 |
Quinolinium, 2-[2-(8-hydroxy-5-quinolyl)vinyl]-1,6-methyl-, iodide (8CI) |
0.0361455178924431 |
0.43096917 |
NSC 112152 |
2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) |
0.0376362543535811 |
0.55893711 |
NSC 123978 |
Sarveroside |
0.0376362543535811 |
0.33559341 |
NSC 134754 |
Null |
0.0376362543535811 |
0.47127551 |
NSC 145168 |
1H-Pyrrole-2,5-dione, 1-(1-hydroxy-2-oxopropyl)- |
0.0376362543535811 |
0.67562766 |
NSC 243022 |
Cinerubin A hydrochloride |
0.0376362543535811 |
0.38038444 |
NSC 31709 |
Quinolinium, 2-[2-(2,5-dimethyl-1-pentyl-1H-pyrrol-3-yl)ethenyl]-1,6-dimethyl-, chloride |
0.0376362543535811 |
0.35142852 |
NSC 327182 |
L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- |
0.0376362543535811 |
0.20064185 |
NSC 340847 |
4-Selenazolecarboxamide, 2-.beta.-D-ribofuranosyl- |
0.0376362543535811 |
0.35349215 |
NSC 376248 |
Nordracorubin |
0.0376362543535811 |
0.36097746 |